{"count": 5, "results": [{"_id": "36394921", "pmid": 36394921, "title": "Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.", "journal": "J Clin Psychopharmacol", "authors": ["Stogios N", "Hahn MK", "Lunsky Y", "Desarkar P", "Agarwal SM"], "date": "2023-01-01T00:00:00Z", "doi": "10.1097/JCP.0000000000001626", "meta_date_publication": "2023 Jan-Feb 01", "meta_volume": "43", "meta_issue": "1", "meta_pages": "60-63", "score": 50257.203, "text_hl": "PURPOSE/BACKGROUND: Individuals with @<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@intellectual and developmental disabilities@@@ (@<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@IDDs@@@) are at increased risk for serious metabolic comorbidities, which is further exacerbated by the high rate of antipsychotic use in this population. ", "citations": {"NLM": "Stogios N, Hahn MK, Lunsky Y, Desarkar P, Agarwal SM. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):60-63. PMID: 36394921", "BibTeX": "@article{36394921, title={Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.}, author={Stogios N and Hahn MK and Lunsky Y and Desarkar P and Agarwal SM}, journal={J Clin Psychopharmacol}, volume={43}, number={1}, pages={60-63}}"}}, {"_id": "39796218", "pmid": 39796218, "title": "Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits.", "journal": "Int J Mol Sci", "authors": ["Yip JMX", "Chiang GSH", "Lee ICJ", "Lehming-Teo R", "Dai K", "Dongol L", "Wang LY", "Teo D", "Seah GT", "Lehming N"], "date": "2025-01-03T00:00:00Z", "doi": "10.3390/ijms26010364", "meta_date_publication": "2025 Jan 3", "meta_volume": "26", "meta_issue": "1", "meta_pages": "", "score": 50245.41, "text_hl": "This review describes our current understanding of the role of the mitochondria in the repurposing of the anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes drugs@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@, @GENE_GLP1R @GENE_2740 @@@GLP-1 receptor@@@ agonists, and SGLT2 inhibitors for additional clinical benefits regarding unhealthy aging, @DISEASE_Post_Acute_COVID_19_Syndrome @DISEASE_MESH:D000094024 @@@long COVID@@@, @<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@mental@@@ @DISEASE_Urinary_Bladder_Neurogenic @DISEASE_MESH:D001750 @@@neurogenerative disorders@@@, and @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@. ", "citations": {"NLM": "Yip JMX, Chiang GSH, Lee ICJ, Lehming-Teo R, Dai K, Dongol L, Wang LY, Teo D, Seah GT, Lehming N. Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. Int J Mol Sci. 2025 Jan 3;26(1):. PMID: 39796218", "BibTeX": "@article{39796218, title={Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits.}, author={Yip JMX and Chiang GSH and Lee ICJ and Lehming-Teo R and Dai K and Dongol L and Wang LY and Teo D and Seah GT and Lehming N}, journal={Int J Mol Sci}, volume={26}, number={1}}"}}, {"_id": "36442649", "pmid": 36442649, "title": "Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.", "journal": "Neuropharmacology", "authors": ["Urbinati C", "Lanzillotta C", "Cosentino L", "Valenti D", "Quattrini MC", "Di Crescenzo L", "Prestia F", "Pietraforte D", "Perluigi M", "Di Domenico F", "Vacca RA", "De Filippis B"], "date": "2023-02-15T00:00:00Z", "doi": "10.1016/j.neuropharm.2022.109350", "meta_date_publication": "2023 Feb 15", "meta_volume": "224", "meta_issue": "", "meta_pages": "109350", "score": 50238.613, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is the most common anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug and a promising therapy for disorders beyond @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, including @DISEASE_Rett_Syndrome @DISEASE_MESH:D015518 @@@Rett syndrome@@@ (@DISEASE_Rett_Syndrome @DISEASE_MESH:D015518 @@@RTT@@@), a rare @DISEASE_Heredodegenerative_Disorders_Nervous_System @DISEASE_MESH:D020271 @@@neurologic disease@@@ characterized by severe @<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@intellectual disability@@@. ", "citations": {"NLM": "Urbinati C, Lanzillotta C, Cosentino L, Valenti D, Quattrini MC, Di Crescenzo L, Prestia F, Pietraforte D, Perluigi M, Di Domenico F, Vacca RA, De Filippis B. Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome. Neuropharmacology. 2023 Feb 15;224():109350. PMID: 36442649", "BibTeX": "@article{36442649, title={Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.}, author={Urbinati C and Lanzillotta C and Cosentino L and Valenti D and Quattrini MC and Di Crescenzo L and Prestia F and Pietraforte D and Perluigi M and Di Domenico F and Vacca RA and De Filippis B}, journal={Neuropharmacology}, volume={224}, pages={109350}}"}}, {"_id": "15372361", "pmid": 15372361, "title": "Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Komori T", "Yoshida F", "Nakamura J", "Miyazaki S", "Miura H", "Iguchi A"], "date": "2004-09-01T00:00:00Z", "doi": "10.1055/s-2004-821187", "meta_date_publication": "2004 Sep", "meta_volume": "112", "meta_issue": "8", "meta_pages": "422-8", "score": 50048.773, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates treatment of @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@obese type 2 diabetic@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@mental retardation@@@; its effects on eating behavior and serum @GENE_LEP @GENE_3952 @@@leptin@@@ levels.", "citations": {"NLM": "Komori T, Yoshida F, Nakamura J, Miyazaki S, Miura H, Iguchi A. Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels. Exp Clin Endocrinol Diabetes. 2004 Sep;112(8):422-8. PMID: 15372361", "BibTeX": "@article{15372361, title={Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.}, author={Komori T and Yoshida F and Nakamura J and Miyazaki S and Miura H and Iguchi A}, journal={Exp Clin Endocrinol Diabetes}, volume={112}, number={8}, pages={422-8}}"}}, {"_id": "30274655", "pmid": 30274655, "title": "Dr. Handen et al. Reply.", "journal": "J Am Acad Child Adolesc Psychiatry", "authors": ["Handen BL", "Veenstra-VanderWeele J", "Anagnostou E", "Aman MG"], "date": "2018-10-01T00:00:00Z", "doi": "10.1016/j.jaac.2018.08.005", "meta_date_publication": "2018 Oct", "meta_volume": "57", "meta_issue": "10", "meta_pages": "793-795", "score": 50043.285, "text_hl": "Instead, they recommended that the results of their current pragmatic trial for children with @DISEASE_Bipolar_Disorder @DISEASE_MESH:D001714 @@@bipolar disorder@@@ (which includes some children with @DISEASE_Autism_Spectrum_Disorder @DISEASE_MESH:D000067877 @@@ASD@@@ and @<m>DISEASE_Intellectual_Disability</m> @DISEASE_MESH:D008607 @@@intellectual disability@@@) would better provide information on relevant moderators and mediators of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s effects. ", "citations": {"NLM": "Handen BL, Veenstra-VanderWeele J, Anagnostou E, Aman MG. Dr. Handen et al. Reply. J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):793-795. PMID: 30274655", "BibTeX": "@article{30274655, title={Dr. Handen et al. Reply.}, author={Handen BL and Veenstra-VanderWeele J and Anagnostou E and Aman MG}, journal={J Am Acad Child Adolesc Psychiatry}, volume={57}, number={10}, pages={793-795}}"}}]}